SCCR30 Is the (zombie) broadcasting treaty back?

Day 1 of SCCR 30 Information Session

Find a few Juicy bits from the long “Information Session on Broadcasting” that started this morning and was continued way passed the planned time of 4pm. It was also the least balanced panel I have ever seen at a WIPO SCCR. A handful of broadcasters, one media analyst, one journalist at the BBC, the WIPO Secretariat represented by Ann Leer (who worked for Paramount, Oxford University Press, BBC, and Financial Times/Pearson and the BBC).

Basically there was no one remotely critical of the proposed treaty nor any public interest representative.

Continue Reading

SCCR 30 June 29: Agenda for the week and Group Statements re Broadcasting and L&Es

SCCR 30 Day 1 June 29, 2015

The SCCR 30 started with the same industry representatives we usually meet here: the MPA, FIJ, IAF, CISAC, Croplife, IFPI, ABA etc… There are also quite a large group of library and archives representatives (IFLA, eifl, Archives etc). However there are many empty chairs for the public interest or pro development NGOs. Some might arrive later?

Continue Reading

UACT Comments to DHHS on WHA: Agenda Item 13.4 Assessment of Progress in Prevention & Control of NCDs

To prepare for the upcoming 68th World Health Assembly (WHA), the U.S. Department of Health & Human Services held a Stakeholder Listening Session on Friday, May 8, 2015, from 10:30am – 12pm in the HHS Humphrey Building – 200 Independence Ave, SW, Washington, DC 20201. All Agenda items for the upcoming WHA are here:
http://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_1-en.pdf
Continue Reading

Uncategorized

Letter from KEI to USPTO regarding implementation of Beijing Treaty

On May 5, 2015, KEI sent a letter to the USPTO regarding the implementation of the Beijing Treaty on Audiovisual Performances. The letter focuses on concerns that KEI and others have expressed that a treaty implementation by amendment of 17 U.S. Code § 1101, regarding the “Unauthorized fixation and trafficking in sound recordings and music videos,” creates problems, because the statute involves a right that is perpetual and not subject to normal copyright exceptions. Continue Reading

Uncategorized

On World Cancer Day, do we celebrate the approval of Pfizer’s $118,200 drug Ibrance?

Today, on World Cancer Day, there has been many great announcements and celebrations.

The FDA approved Pfizer’s new drug Ibrance (INN: palbociclib) for the treatment of metastatic (advanced) breast cancer to be used in combination with letrozole based on a 165 person trial at UCLA’s cancer center. (FDA press release here, ABC story here.)

Continue Reading

Uncategorized

UACT letter to Professor DiMasi, asking for answer to five questions about new R&D cost study

February 4, 2015 is World Cancer Day. The rapidly increasing cost of cancer drugs should be broadly discussed. The Union for Affordable Cancer Treatment (UACT), a union of people affected by cancer (http://cancerunion.org/) is asking the author and co-author of the “Tufts Cost Study,” –a not-yet-released “study” used to justify high prices of drugs without providing data– to address the following questions:

Continue Reading

Uncategorized